GOCOVRI: payments to doctors
Payments that named GOCOVRI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.8M
- Providers
- 5,001
- Transactions
- 38,299
- Average per transaction
- $151
The per-transaction average — $151 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,001 providers the average total is $1,157, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| MDD US Operations, LLC | $3,509,432 | 60.7% |
| Adamas Pharmaceuticals, Inc. | $2,275,340 | 39.3% |
| Supernus Pharmaceuticals, Inc. | $128 | 0.0% |